NCT06248801View on ClinicalTrials.gov

Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 5, 2024

Primary Completion Date

October 1, 2024

Study Completion Date

October 15, 2024

Conditions
Healthy Subjects
Interventions
DRUG

Vildagliptin and Metformin-Test product

Vildagliptin and Metformin tablets 50/1000 mg manufactured by Mylan Laboratories Limited, India

DRUG

Vildagliptin and Metformin-Reference product

Vildagliptin and Metformin tablets 50/1000 mg manufactured by NOVARTIS PHARMA PRODUKTIONS GmbH, Germany.

All Listed Sponsors
lead

Bio-innova Co., Ltd

INDUSTRY

NCT06248801 - Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets | Biotech Hunter | Biotech Hunter